Protective particles allow engineered probiotics to report gut disease
Rice U. bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart therapeutics.
Rice establishes 3-year partnership with Indian Institute of Technology Kanpur
Rice University and the Indian Institute of Technology Kanpur have taken an important next step in their strategic research and education partnership with the announcement of the first recipients of the Rice-IITK Strategic Collaboration Award program.
Weaker transcription factors are better when they work together
Rice bioengineer Caleb Bashor and colleagues have developed a generalizable method to address “off-target” gene activation, a significant problem in the field of synthetic biology. Taking a cue from nature, the researchers showed they could all but eliminate the activation of off-target genes by designing weak transcription factors that cooperatively assemble.
Cost-effective jaundice testing developed for low-resource hospitals
The Rice360 Institute for Global Health Technologies has validated the accuracy of its latest testing technology for newborn jaundice. BiliDx addresses a critical gap in the availability of accurate, affordable, point-of-care jaundice testing in low-resource hospitals.
Rice U. program in Costa Rica promotes medical innovation
Rice University’s Global Medical Innovation program combines engineering, business and clinical training to help students solve real-world medical needs.
New software designs optimized, personalized treatments for movement impairments
A team of Rice University engineers has launched open-source software that constructs and uses personalized computer models of how individual patients move to optimize treatments for neurologic and orthopedic mobility impairments.
Rice researchers earn prestigious Defense Department grants
Rice professors Qimiao Si and Jeffrey Tabor are recipients of prestigious 2023 Vannevar Bush Faculty Fellowships from the Department of Defense.
Four Rice undergraduates latest Owls to win coveted Goldwater Scholarship
Rising Rice seniors Maria Hancu, Alex Lin, Ryan Wang and Ruofeng “Charlie” Liu are the latest Owls to win the coveted Goldwater Scholarship, one of the most prestigious honors bestowed each year upon pioneering STEM undergraduates across the country planning to pursue doctoral degrees.
NIH grant backs Rice lab’s sickle cell disease research
Rice University bioengineer Gang Bao and his team have won a grant from the National Institutes of Health to address critical questions surrounding the safety and efficacy of using gene editing to treat sickle cell disease.
Rice chemist wins $3.2M National Cancer Institute grant
Rice University chemist Han Xiao has won a $3.2 million research project (R01) grant from the National Cancer Institute to develop the first tissue-specific epigenetic inhibitor drug to treat bone metastasis.
Reporters broadcast live, on-the-scene, inside living cells
Synthetic biologists from Rice University and Princeton University have demonstrated “live reporter” technology that can reveal the workings of signaling networks in living cells with far greater precision than current methods. The first-of-its-kind reporting tool can show how quickly signaling networks respond and how responses vary from cell to cell in time and space.
DNA test could broaden access to cervical cancer screening
Rice bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.
Antonios Mikos wins European Society for Biomaterials award
Rice University bioengineer Antonios Mikos has won the 2023 International Award of the European Society for Biomaterials.
Neuroengineering’s InterfaceRice 2023 conference draws 160-plus
More than 160 leaders in neurotechnology, neuroscience, neuroengineering and neurosurgery attended InterfaceRice 2023, the inaugural conference of the Rice Neuroengineering Initiative, May 18-19.
Rice, Baylor developing ‘glyco-immune’ checkpoint inhibitor
Researchers from Rice and Baylor College of Medicine are developing a first-of-its-kind “glyco-immune” checkpoint inhibitor for breast cancer survivors who develop metastatic bone cancer.
